GradedCalls Analysts
Loading the ledger…
GradedCalls Analysts
Loading the ledger…
NYSE · Healthcare
Eli Lilly · Pharmaceuticals. Historical grades below use the calls in this ledger. The list is each analyst’s latest recommendation. The bar under it is the direction for grading, not a live street tally.
Direction for grading, from the latest active call of each analyst. Strong Buy, Buy, Overweight, and Outperform count as Buy. Hold, Neutral, and Equal-Weight count as Hold. Underperform, Underweight, and Sell count as Sell. The recommendation on the call — Target raise, Upgrade to Buy, Reiterate Overweight — is a separate label.
Overall factor · 90D
16.1/100Average of active call grades
GC score2/10GC 1→GC 10
GC 1–4. Under 40 is WEAK on the GC Scale.
The overall factor is the average of the 0–100 grades on active calls at this horizon. A call superseded by a later note on the same ticker within 90 days stays visible and does not enter this average, the GC score, or the hit rate. How this is computed
Active graded
| Analyst | Firm | N | Hit | Overall factor/100 · GC 1–10 |
|---|---|---|---|---|
| Courtney Breen | Bernstein | 1 | 0% | 44.5/1005/10 |
| Jason Gerberry | BofA | 1 | 0% | 17.5/1002/10 |
| Michael Yee | UBS | 1 | 0% | 2.5/100 |
History only. A later call on the same ticker within 90 days replaced these. The notes stay. They do not enter the overall factor.
| Date | Analyst | Recommendation | Directionfor grading | Target | Then | After | Return | Grade |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2026 Nullified Nullified — superseded by later call on Oct 8, 2026 (within 90 days). Later call | Carter GouldCantor | Target raise Desk rating stays Overweight | Buy | — | — | Not scored | ||
| Jul 13, 2026 |
4
In this factor
Superseded
3
Visible, not scored
Hit rate
0%
Active calls only
If followed
+0.6%
Active directional calls
Active calls on LLY were a full hit 0% of the time. Hit rate is not the rank.
| Geoff Meacham | Citi | 1 | 0% | 0/100—/10 EXIT LIQUIDITY |
Nullified — superseded by later call on Sep 18, 2026 (within 90 days). Later call
| Seamus FernandezGuggenheim |
| Target raise Desk rating stays Buy |
| Buy |
| $1,179.27 |
| -0.1% |
| Miss Not scored |
| Jul 8, 2026 Nullified Nullified — superseded by later call on Aug 7, 2026 (within 90 days). Later call | Robyn KarnauskasTruist | Target raise Desk rating stays Buy | Buy | $1,157.49 | -4.7% | Miss Not scored |